You are viewing: Canada Structural Heart Devices Market analysis

The Canada Structural Heart Devices Market was valued at $616.1 Million in 2024 and projected to reach to $985.8 Million by 2029, representing a compound annual growth rate of 9.9%. Canada's structural heart devices market is positioned for sustained growth through 2029, driven by demographic shifts and healthcare modernization.

Canada Structural Heart Devices Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Canada Structural Heart Devices Market Trends and Insights

  • This expansion reflects Canada's aging population, increasing prevalence of valvular and congenital heart diseases, and rising adoption of minimally invasive interventional procedures.
  • Canada's healthcare system continues to invest in advanced cardiac technologies, supported by strong reimbursement frameworks and clinical evidence driving adoption of transcatheter solutions. The Canadian market benefits from a well-established medical device infrastructure and proximity to North American innovation hubs.
  • Between 2024 and 2029, Canada is expected to see accelerated uptake of transcatheter aortic valve replacement (TAVR), left atrial appendage (LAA) closure devices, and structural repair solutions.
  • Canada's regulatory environment through Health Canada and provincial health authorities facilitates timely market access, enabling manufacturers to introduce next-generation devices that address unmet clinical needs in structural heart disease management..

Key Market Statistics

  • CAGR (2024-2029) 9.9% CAGR
  • Market Size, 2024 ~USD 616.1 Million
  • Forecast, 2029 ~USD 985.8 Million
  • Country Canada

Canada Structural Heart Devices Market Overview

Market Size & Growth :

Canada's structural heart devices market reached $616.1 million in 2024 and is projected to grow at a CAGR of 9.9% through 2029, reaching $985.8 million, outpacing the global growth rate of 9.5%.

Aging Population Driver :

Canada's rapidly aging demographic, with increasing life expectancy and a growing senior population, is driving higher incidence of valvular and congenital heart diseases, creating sustained demand for structural heart interventions.

Minimally Invasive Adoption :

Canadian healthcare providers are increasingly adopting minimally invasive interventional procedures for structural heart conditions, reducing patient recovery times and hospital stays while improving clinical outcomes.

Healthcare System Investment :

Canada's publicly funded healthcare system continues to prioritize investment in advanced cardiac technologies and infrastructure, supporting market expansion and ensuring equitable access to structural heart devices across provinces.

Canada Structural Heart Devices Market Dynamics

  • The country's aging population and rising prevalence of heart valve disorders create consistent demand for innovative treatment solutions.
  • Provincial healthcare systems are increasingly allocating budgets toward advanced interventional cardiology, supporting adoption of transcatheter and minimally invasive devices. The competitive landscape in Canada is characterized by strong presence of global device manufacturers and growing interest from regional players.
  • Regulatory pathways through Health Canada remain streamlined for innovative technologies, facilitating faster market entry.
  • Continued investment in cardiac centers of excellence and interventional cardiology training programs will further accelerate market penetration and procedural volumes across major Canadian healthcare networks..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Canada's structural heart devices market is valued at $616.1 million in 2024 and will reach $985.8 million by 2029, representing a 9.9% CAGR.
    • Canada's aging demographic and rising cardiovascular disease burden are primary drivers of structural heart device adoption across the country.
    • Minimally invasive transcatheter procedures are gaining traction in Canada, supported by favorable reimbursement and clinical evidence.
    • Canada's integrated healthcare system and regulatory framework enable rapid adoption of innovative structural heart technologies.

    Structural Heart Devices Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment TAVR/TAVI PROCEDURES (Type)
    Forecast Period 2024-2029
    Growth Rate CAGR of 9.5% from 2024 to 2029
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 16.32 (2024)
    Revenue Forecast (Billions) ~USD 25.69 (2029)
    Segments Covered Procedure, Type, Product, End User, Accessories

    Canada Structural Heart Devices Market Report Segmentation

    5 segment dimensions are covered across the global market.

    By Procedure

    • Repair Procedures
    • Replacement Procedures

    By Type

    • Annuloplasty
    • Biological Valves
    • Catheters
    • Closure Procedures
    • Guidewires
    • Mechanical Valves
    • Other Accessories
    • Savr Procedures
    • Sheaths
    • Surgical Heart Valves
    • Surgical Valves
    • Tavr/Tavi Procedures
    • Teer Procedures
    • Tmvr Procedures
    • Transcatheter Aortic Valve Replacement (Tavr)
    • Transcatheter Heart Valves
    • Transcatheter Mitral Valve Replacement (Tmvr)
    • Valvuloplasty

    By Product

    • Accessories
    • Annuloplasty Rings
    • Heart Valve Devices
    • Occluders, Closure Systems And Delivery Systems
    • Occluders, Closure Systems, And Delivery Systems

    By End User

    • Ambulatory Surgical Centers
    • Ambulatory Surgical Centres
    • Hospitals
    • Other Accessories
    • Other End Users
    • Other End Users (Cath Labs, Cardiac Centers )
    • Other End Users (Cath Labs, Cardiac Centers)
    • Other End Users (Cath Labs, Cardiac Centres)
    • Others End Users

    By Accessories

    • Catheters
    • Guidewires
    • Other Accessories
    • Sheaths

    CANADA: STRUCTURAL HEART DEVICES MARKET, BY END USER, 2022–2029

    Segment20222023202420252026202720282029CAGR (%)
    AMBULATORY SURGICAL CENTERS111.2120.7130.5141.2152.8165.6179.6194.98.4
    HOSPITALS769.3839.9914.1995.61084.51182.91291.31410.99.1
    OTHER END USERS108.9120131.8144.9159.3175.4193.3213.110.1
    TOTAL989.51080.61176.31281.61396.71523.81664.21818.99.1

    Target Audience

    • Medical Device Manufacturers : Device companies seeking to expand or establish presence in Canada need market sizing, competitive intelligence, and regulatory pathway information to optimize product launches and market penetration strategies.
    • Healthcare System Administrators : Provincial health authorities and hospital networks require market data to inform capital equipment budgeting, procurement decisions, and technology adoption planning for structural heart programs.
    • Investment & Private Equity Firms : Investors evaluating opportunities in Canadian healthcare need comprehensive market analysis, growth forecasts, and competitive landscape data to assess investment returns and portfolio company potential.
    • Interventional Cardiologists & Clinical Leaders : Cardiac specialists and hospital administrators need market insights to advocate for advanced device adoption, justify program expansion, and understand emerging treatment trends in their regions.
    • Market Research & Consulting Professionals : Analysts and consultants supporting healthcare clients require detailed Canada-specific data, forecasts, and market segmentation to deliver credible strategic recommendations and competitive assessments.

    Reasons to Buy this Report

    • Market-Specific Growth Insights : Understand Canada's 9.9% CAGR trajectory and identify high-growth opportunities within provincial healthcare systems and private cardiac centers across the country.
    • Demographic & Clinical Trends : Access detailed analysis of Canada's aging population dynamics, prevalence of valvular diseases, and shifting treatment patterns to inform product development and market entry strategies.
    • Regulatory & Reimbursement Landscape : Gain insights into Health Canada approval pathways, provincial reimbursement mechanisms, and healthcare funding priorities specific to structural heart devices.
    • Competitive Positioning : Benchmark against competitors operating in Canada's market, identify white space opportunities, and understand market share dynamics among global and regional players.
    • Strategic Market Planning : Develop evidence-based go-to-market strategies tailored to Canada's healthcare system structure, provincial variations, and key opinion leader networks in interventional cardiology.

    Frequently asked questions

    What is the current size of Canada's structural heart devices market?

    Canada's structural heart devices market was valued at $616.1 million in 2024 and is projected to grow to $985.8 million by 2029.

    What is the expected growth rate for Canada's structural heart devices market?

    Canada's structural heart devices market is expected to grow at a compound annual growth rate (CAGR) of 9.9% from 2024 to 2029.

    What are the main drivers of growth in Canada's structural heart devices market?

    Key drivers include Canada's aging population, increasing prevalence of valvular heart disease, rising adoption of minimally invasive procedures, and strong healthcare reimbursement for transcatheter interventions.

    Which structural heart devices are most commonly used in Canada?

    Transcatheter aortic valve replacement (TAVR) devices, left atrial appendage (LAA) closure devices, and structural repair solutions are among the most widely adopted in Canada.

    How does Canada's regulatory environment support structural heart device adoption?

    Health Canada and provincial health authorities provide streamlined approval pathways and favorable reimbursement frameworks that facilitate timely market access for innovative structural heart technologies.

    RESEARCH METHODOLOGY

    The study involved four major activities to estimate the current size of the Structural heart devices market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

    Secondary Research

    In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of Structural heart devices market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    Extensive primary research was conducted after obtaining information regarding the Structural heart devices market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand and supply sides across major countries of North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Primary data was collected through questionnaires, emails, and telephonic interviews. The primary sources from the supply side included various industry experts, such as Chief X Officers (CXOs), Vice Presidents (VPs), Directors from business development, marketing, product development/innovation teams, and related key executives from manufacturers; distributors operating in the Structural heart devices market.; and key opinion leaders.

    Primary interviews were conducted to gather insights such as market statistics, data on revenue collected from the products and services, market breakdowns, market size estimations, market forecasting, and data triangulation. Primary research also helped in understanding the various trends related to technology, application, vertical, and region. Stakeholders from the demand side customers/end users who are using infection control products were interviewed to understand the buyer’s perspective on the suppliers, products, and their current usage and the future outlook of their business, which will affect the overall market.

    The following is a breakdown of the primary respondents:

    Structural Heart Devices Market

    Note 1: C-level primaries include CEOs, COOs, CTOs, and VPs.

    Note 2: Other primaries include sales managers, marketing managers, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue.

    As of 2023: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3=< USD 500 million.

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    The research methodology used to estimate the size of the Structural heart devices market includes the following details.

    The market sizing of the market was undertaken from the global side.

    Country-level Analysis: The size of the Structural heart devices market was obtained from the annual presentations of leading players and secondary data available in the public domain. The share of products in the overall Structural heart devices market was obtained from secondary data and validated by primary participants to arrive at the total Structural heart devices market. Primary participants further validated the numbers.

    Geographic market assessment (by region & country): The geographic assessment was done using the following approaches:

    Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends

    Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)

    At each point, the assumptions and approaches were validated through industry experts contacted during primary research. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall Structural heart devices market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.

    Global Structural heart dsevices market size : Top-Down and Bottom-Up Approach

    Structural Heart Devices Market

    Data Triangulation

    The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Structural heart devices market.

    Market Definition

    Structural Heart devices are used to treat conditions such as aortic valve disease, mitral valve disease, atrial septal defect, ventricular septal defect, hypertrophic cardiomyopathy, and tricuspid and pulmonic valve disease. Structural heart devices can be used to close holes in the heart, open narrowed heart valves, or replace damaged valves.

    Stakeholders

    • Medical Device Manufacturers
    • Cardiologists
    • Interventional Cardiologist
    • Healthcare institutions (hospitals and outpatient clinics)
    • Distributors and suppliers
    • Research institutes
    • Health insurance payers
    • Market research and consulting firms

    Report Objectives

    • To define, describe, segment, and forecast the global Structural heart devices market by product, procedure, end user, and region.
    • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
    • To analyze micromarkets1 concerning individual growth trends, prospects, and contributions to the overall Structural heart devices market.
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players.
    • To forecast the size of the Structural heart devices market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To profile key players in the global Structural heart devices market and comprehensively analyze their core competencies2 and market shares.
    • To track and analyze competitive developments such as acquisitions, expansions, partnerships, agreements, and collaborations; and product launches and approvals.
    • To benchmark players within the Structural heart devices market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

    Get the Full Structural Heart Devices Market Report

    Full forecast, segment splits, and company analysis for all Structural Heart Devices Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status